Nektar Therapeutics Increase (Decrease) in Inventories
Nektar Therapeutics (NKTR) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-03-13
- Nektar Therapeutics increase (decrease) in inventories for the quarter ending 2025-12-31 was $0.00.
- Nektar Therapeutics increase (decrease) in inventories for the quarter ending 2025-09-30 was $0.00.
- Nektar Therapeutics increase (decrease) in inventories for the quarter ending 2025-06-30 was $0.00.
- Nektar Therapeutics increase (decrease) in inventories for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Nektar Therapeutics increase (decrease) in inventories for fiscal 2025 was $0.00.
- Nektar Therapeutics increase (decrease) in inventories for fiscal 2024 was -$497.00K.
- Nektar Therapeutics increase (decrease) in inventories for fiscal 2023 was -$699.00K, a 120.55% decline from fiscal 2022.
- Nektar Therapeutics increase (decrease) in inventories for fiscal 2022 was $3.40M, a 568.17% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-13 | $0.00 derived: sum of 3 quarters · filed 2026-03-13 | $0.00 10-K · filed 2026-03-13 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | -$1.30M derived: sum of 4 quarters · filed 2026-03-13 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | -$1.30M derived: sum of 3 quarters · filed 2026-03-13 | -$1.43M derived: sum of 4 quarters · filed 2026-03-13 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | -$1.30M derived: sum of 2 quarters · filed 2026-03-13 | -$1.43M derived: sum of 3 quarters · filed 2026-03-13 | -$1.64M derived: sum of 4 quarters · filed 2026-03-13 | |||
| 2024-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$1.43M derived: sum of 2 quarters · filed 2026-03-13 | -$1.64M derived: sum of 3 quarters · filed 2026-03-13 | -$497.00K 10-K · filed 2026-03-13 | |||
| 2024-09-30 | -$123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$335.00K derived: sum of 2 quarters · filed 2025-11-07 | $808.00K 10-Q · filed 2025-11-07 | -$263.00K derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | -$212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $931.00K 10-Q · filed 2025-08-08 | -$140.00K derived: sum of 3 quarters · filed 2025-08-08 | -$2.51M derived: sum of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | $1.14M 10-Q · filed 2025-05-09 | $72.00K derived: sum of 2 quarters · filed 2025-05-09 | -$2.29M derived: sum of 3 quarters · filed 2025-05-09 | -$1.54M derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$3.44M derived: sum of 2 quarters · filed 2025-03-14 | -$2.68M derived: sum of 3 quarters · filed 2025-03-14 | -$699.00K 10-K · filed 2025-03-14 | |||
| 2023-09-30 | -$2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.61M derived: sum of 2 quarters · filed 2024-11-08 | $372.00K 10-Q · filed 2024-11-08 | $517.00K derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | $754.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $2.74M 10-Q · filed 2024-08-09 | $1.49M 10-Q · filed 2023-08-09 | $2.88M derived: sum of 3 quarters · filed 2024-08-09 | $4.97M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $1.99M 10-Q · filed 2024-05-10 | $1.03M 10-Q · filed 2023-05-10 | $2.13M derived: sum of 2 quarters · filed 2024-05-10 | $4.22M derived: sum of 3 quarters · filed 2024-05-10 | $5.81M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.23M derived: sum of 2 quarters · filed 2024-03-05 | $3.82M derived: sum of 3 quarters · filed 2024-03-05 | $3.40M 10-K · filed 2024-03-05 | |||
| 2022-09-30 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.68M derived: sum of 2 quarters · filed 2023-11-08 | $3.26M 10-Q · filed 2023-11-08 | $3.73M derived: sum of 4 quarters · filed 2024-03-05 | |||
| 2022-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.17M 10-Q · filed 2023-08-09 | $1.64M derived: sum of 3 quarters · filed 2024-03-05 | $2.35M derived: sum of 4 quarters · filed 2024-03-05 | |||
| 2022-03-31 | -$422.00K 10-Q · filed 2023-05-10 | $49.00K derived: sum of 2 quarters · filed 2024-03-05 | $763.00K derived: sum of 3 quarters · filed 2024-03-05 | -$1.43M derived: sum of 4 quarters · filed 2024-03-05 | |||
| 2021-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.19M derived: sum of 2 quarters · filed 2024-03-05 | -$1.01M derived: sum of 3 quarters · filed 2024-03-05 | $509.00K 10-K · filed 2024-03-05 | |||
| 2021-09-30 | $714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$1.48M derived: sum of 2 quarters · filed 2022-11-04 | $38.00K 10-Q · filed 2022-11-04 | $2.44M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$676.00K 10-Q · filed 2022-08-05 | $1.72M derived: sum of 3 quarters · filed 2023-02-28 | $2.03M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $1.52M 10-Q · filed 2022-05-06 | $3.92M derived: sum of 2 quarters · filed 2023-02-28 | $4.22M derived: sum of 3 quarters · filed 2023-02-28 | $2.49M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.71M derived: sum of 2 quarters · filed 2023-02-28 | $972.00K derived: sum of 3 quarters · filed 2023-02-28 | $2.63M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $308.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$1.43M derived: sum of 2 quarters · filed 2021-11-05 | $227.00K 10-Q · filed 2021-11-05 | -$828.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$81.00K 10-Q · filed 2021-08-06 | -$1.14M derived: sum of 3 quarters · filed 2022-03-01 | -$604.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $1.66M 10-Q · filed 2021-05-07 | $600.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.13M derived: sum of 3 quarters · filed 2022-03-01 | $2.54M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$523.00K derived: sum of 2 quarters · filed 2022-03-01 | $887.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.28M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $532.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.94M derived: sum of 2 quarters · filed 2020-11-06 | $2.34M 10-Q · filed 2020-11-06 | $424.00K derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.81M 10-Q · filed 2020-08-07 | -$108.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.30M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-03-31 | $397.00K 10-Q · filed 2020-05-08 | -$1.52M derived: sum of 2 quarters · filed 2021-02-26 | -$106.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.10M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2018-12-31 | -$1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$503.00K derived: sum of 2 quarters · filed 2021-02-26 | $706.00K derived: sum of 3 quarters · filed 2021-02-26 | $655.00K 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.62M derived: sum of 2 quarters · filed 2019-11-07 | $2.57M 10-Q · filed 2019-11-07 | -$358.00K derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.16M 10-Q · filed 2019-08-09 | -$1.77M derived: sum of 3 quarters · filed 2020-02-28 | $876.00K derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | -$51.00K 10-Q · filed 2019-05-09 | -$2.98M derived: sum of 2 quarters · filed 2020-02-28 | -$333.00K derived: sum of 3 quarters · filed 2020-02-28 | -$2.34M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2017-12-31 | -$2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$282.00K derived: sum of 2 quarters · filed 2020-02-28 | -$2.29M derived: sum of 3 quarters · filed 2020-02-28 | -$383.00K 10-K · filed 2020-02-28 | |||
| 2017-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $638.00K derived: sum of 2 quarters · filed 2018-11-08 | $2.54M 10-Q · filed 2018-11-08 | $2.90M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | -$2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$101.00K 10-Q · filed 2018-08-09 | $254.00K derived: sum of 3 quarters · filed 2019-03-01 | $746.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | $1.91M 10-Q · filed 2018-05-10 | $2.26M derived: sum of 2 quarters · filed 2019-03-01 | $2.75M derived: sum of 3 quarters · filed 2019-03-01 | $1.77M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $847.00K derived: sum of 2 quarters · filed 2019-03-01 | -$141.00K derived: sum of 3 quarters · filed 2019-03-01 | -$237.00K 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$496.00K derived: sum of 2 quarters · filed 2017-11-08 | -$592.00K 10-Q · filed 2017-11-08 | $402.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | -$988.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.08M 10-Q · filed 2017-08-09 | -$90.00K derived: sum of 3 quarters · filed 2018-03-01 | $138.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | -$96.00K 10-Q · filed 2017-05-10 | $898.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.13M derived: sum of 3 quarters · filed 2018-03-01 | -$1.26M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $994.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.22M derived: sum of 2 quarters · filed 2018-03-01 | -$1.17M derived: sum of 3 quarters · filed 2018-03-01 | -$1.61M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$2.16M derived: sum of 2 quarters · filed 2016-11-04 | -$2.60M 10-Q · filed 2016-11-04 | -$1.34M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | -$2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$2.83M 10-Q · filed 2016-08-04 | -$1.57M derived: sum of 3 quarters · filed 2017-03-01 | -$3.99M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | -$441.00K 10-Q · filed 2016-05-04 | $816.00K derived: sum of 2 quarters · filed 2017-03-01 | -$1.60M derived: sum of 3 quarters · filed 2017-03-01 | -$361.00K derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$1.16M derived: sum of 2 quarters · filed 2017-03-01 | $80.00K derived: sum of 3 quarters · filed 2017-03-01 | -$500.00K 10-K · filed 2017-03-01 | |||
| 2014-09-30 | -$2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$1.18M derived: sum of 2 quarters · filed 2015-11-06 | -$1.76M 10-Q · filed 2015-11-06 | -$3.38M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $659.00K 10-Q · filed 2015-08-06 | -$965.00K derived: sum of 3 quarters · filed 2016-02-29 | -$6.37M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$580.00K 10-Q · filed 2015-05-01 | -$2.20M derived: sum of 2 quarters · filed 2016-02-29 | -$7.61M derived: sum of 3 quarters · filed 2016-02-29 | -$5.51M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$7.03M derived: sum of 2 quarters · filed 2016-02-29 | -$4.93M derived: sum of 3 quarters · filed 2016-02-29 | -$4.82M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$3.31M derived: sum of 2 quarters · filed 2014-11-07 | -$3.19M 10-Q · filed 2014-11-07 | -$1.68M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $2.21M 10-Q · filed 2014-08-01 | $3.73M derived: sum of 3 quarters · filed 2015-02-26 | $5.76M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-03-31 | $112.00K 10-Q · filed 2014-05-08 | $1.63M derived: sum of 2 quarters · filed 2015-02-26 | $3.67M derived: sum of 3 quarters · filed 2015-02-26 | $4.27M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2012-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $3.55M derived: sum of 2 quarters · filed 2015-02-26 | $4.16M derived: sum of 3 quarters · filed 2015-02-26 | $5.61M 10-K · filed 2015-02-26 | |||
| 2012-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.65M derived: sum of 2 quarters · filed 2013-11-07 | $4.10M 10-Q · filed 2013-11-07 | -$4.10M 10-Q · filed 2012-11-09 | $12.88M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2012-06-30 | $607.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.06M 10-Q · filed 2013-08-09 | $10.84M derived: sum of 3 quarters · filed 2014-02-27 | $4.92M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-03-31 | $1.45M 10-Q · filed 2013-05-09 | $10.23M derived: sum of 2 quarters · filed 2014-02-27 | $4.31M derived: sum of 3 quarters · filed 2014-02-27 | $2.40M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2011-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $2.86M derived: sum of 2 quarters · filed 2014-02-27 | $944.00K derived: sum of 3 quarters · filed 2014-02-27 | $5.39M 10-K · filed 2014-02-27 | |||
| 2011-09-30 | -$5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$7.83M derived: sum of 2 quarters · filed 2012-11-09 | -$3.39M 10-Q · filed 2012-11-09 | $3.39M 10-Q · filed 2011-11-04 | -$7.58M derived: sum of 4 quarters · filed 2013-03-01 | ||
| 2011-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $2.53M 10-Q · filed 2012-08-09 | -$1.66M derived: sum of 3 quarters · filed 2013-03-01 | $20.00K derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-03-31 | $4.45M 10-Q · filed 2012-05-04 | $252.00K derived: sum of 2 quarters · filed 2013-03-01 | $1.94M derived: sum of 3 quarters · filed 2013-03-01 | $3.01M derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2010-12-31 | -$4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$2.51M derived: sum of 2 quarters · filed 2013-03-01 | -$1.44M derived: sum of 3 quarters · filed 2013-03-01 | $795.00K 10-K · filed 2013-03-01 | |||
| 2010-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $2.76M derived: sum of 2 quarters · filed 2011-11-04 | $4.99M 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $3.31M 10-Q · filed 2011-08-05 | |||||
| 2010-03-31 | $2.23M 10-Q · filed 2011-04-29 | ||||||
| 2009-12-31 | -$2.85M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |